Shopping Cart 0
Cart Subtotal
AED 0

Eisai Inc - Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

Eisai Inc-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

Eisai Inc (Eisai) is a healthcare company, which focuses on the discovery, development and marketing of pharmaceutical products. The company's major products include Aricept for Alzheimer's treatment, Aciphex for acid reflux, Akynzeo for nausea and vomiting dring the course of cancer chemotherapy, Aloxi anti-nausea medication injection, Banzel for adjunctive treatment and Panretin for the treatment of skin lesions in AIDS-related Kaposi's sarcoma. The company's research and development activities focus on therapeutic areas such as neuroscience; cancer, antibody-based programs; vascular, inflammatory and immunological reaction. Eisai established partnerships and collaborations with global companies such as Pfizer Inc., Janssen Pharmaceutica Inc., and Elan Pharma International Limited and Elan Pharmaceutical Inc for the development and distribution of drugs. The company is a subsidiary of Eisai Co., Ltd. and is headquartered in New Jersey, the US.

Eisai Inc Key Recent Developments

Dec 05,2019: Beneath the Breast Campaign from Eisai and METAvivor supports relationship challenges commonly faced by people living with Metastatic Breast Cancer and their loved ones

Aug 26,2019: Priya Chaturvedi, Ph.D., appointed Vice President of Global Clinical Quality Assurance at Eisai

Jul 09,2019: Eisai commemorates opening of center for genetics guided dementia discovery in Cambridge, Massachusetts

Jun 04,2019: Patrick Coyle appointed Vice President and Chief Financial Officer of Eisai

May 29,2019: Adriana Herrera appointed senior vice president, Americas commercial oncology at Eisai

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Eisai Inc-Key Facts

Eisai Inc-Key Employees

Eisai Inc-Key Employee Biographies

Eisai Inc-Major Products and Services

Eisai Inc-History

Eisai Inc-Company Statement

Eisai Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Eisai Inc-Business Description

Eisai Inc-Corporate Strategy

Eisai Inc-SWOT Analysis

SWOT Analysis-Overview

Eisai Inc-Strengths

Eisai Inc-Weaknesses

Eisai Inc-Opportunities

Eisai Inc-Threats

Eisai Inc-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eisai Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Eisai Inc, Recent Deals Summary

Section 4-Company's Recent Developments

Dec 05, 2019: Beneath the Breast Campaign from Eisai and METAvivor supports relationship challenges commonly faced by people living with Metastatic Breast Cancer and their loved ones

Aug 26, 2019: Priya Chaturvedi, Ph.D., appointed Vice President of Global Clinical Quality Assurance at Eisai

Jul 09, 2019: Eisai commemorates opening of center for genetics guided dementia discovery in Cambridge, Massachusetts

Jun 04, 2019: Patrick Coyle appointed Vice President and Chief Financial Officer of Eisai

May 29, 2019: Adriana Herrera appointed senior vice president, Americas commercial oncology at Eisai

May 02, 2019: Eisai deepens its commitment to Alzheimer's disease with key executive appointments

May 01, 2019: Eisai acquires rights to lemborexant from Purdue Pharma

Mar 13, 2019: TRIA to design new dementia discovery center for Eisai

Sep 06, 2018: Oncodesign furthers its cooperation with Eisai, started 12 years ago

Aug 31, 2018: XingImaging announces alzheimer's disease PET imaging in Mainland China

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eisai Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Eisai Inc, Key Facts

Eisai Inc, Key Employees

Eisai Inc, Key Employee Biographies

Eisai Inc, Major Products and Services

Eisai Inc, History

Eisai Inc, Other Locations

Eisai Inc, Subsidiaries

Eisai Inc, Key Competitors

Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eisai Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Eisai Inc, Recent Deals Summary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Eisai Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Koronis Pharma Inc

Abraxis BioScience Inc

White River Health System

Research Foundation for Mental Hygiene Inc

Wellstat Therapeutics Corp

Salix Pharmaceuticals Ltd

Ceregene Inc

Adlyfe Inc

Predictive Biosciences Inc

AstraZeneca Plc

Company Profile

Company Profile Title

Eisai Inc-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

Eisai Inc (Eisai) is a healthcare company, which focuses on the discovery, development and marketing of pharmaceutical products. The company's major products include Aricept for Alzheimer's treatment, Aciphex for acid reflux, Akynzeo for nausea and vomiting dring the course of cancer chemotherapy, Aloxi anti-nausea medication injection, Banzel for adjunctive treatment and Panretin for the treatment of skin lesions in AIDS-related Kaposi's sarcoma. The company's research and development activities focus on therapeutic areas such as neuroscience; cancer, antibody-based programs; vascular, inflammatory and immunological reaction. Eisai established partnerships and collaborations with global companies such as Pfizer Inc., Janssen Pharmaceutica Inc., and Elan Pharma International Limited and Elan Pharmaceutical Inc for the development and distribution of drugs. The company is a subsidiary of Eisai Co., Ltd. and is headquartered in New Jersey, the US.

Eisai Inc Key Recent Developments

Dec 05,2019: Beneath the Breast Campaign from Eisai and METAvivor supports relationship challenges commonly faced by people living with Metastatic Breast Cancer and their loved ones

Aug 26,2019: Priya Chaturvedi, Ph.D., appointed Vice President of Global Clinical Quality Assurance at Eisai

Jul 09,2019: Eisai commemorates opening of center for genetics guided dementia discovery in Cambridge, Massachusetts

Jun 04,2019: Patrick Coyle appointed Vice President and Chief Financial Officer of Eisai

May 29,2019: Adriana Herrera appointed senior vice president, Americas commercial oncology at Eisai

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Eisai Inc-Key Facts

Eisai Inc-Key Employees

Eisai Inc-Key Employee Biographies

Eisai Inc-Major Products and Services

Eisai Inc-History

Eisai Inc-Company Statement

Eisai Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Eisai Inc-Business Description

Eisai Inc-Corporate Strategy

Eisai Inc-SWOT Analysis

SWOT Analysis-Overview

Eisai Inc-Strengths

Eisai Inc-Weaknesses

Eisai Inc-Opportunities

Eisai Inc-Threats

Eisai Inc-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eisai Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Eisai Inc, Recent Deals Summary

Section 4-Company's Recent Developments

Dec 05, 2019: Beneath the Breast Campaign from Eisai and METAvivor supports relationship challenges commonly faced by people living with Metastatic Breast Cancer and their loved ones

Aug 26, 2019: Priya Chaturvedi, Ph.D., appointed Vice President of Global Clinical Quality Assurance at Eisai

Jul 09, 2019: Eisai commemorates opening of center for genetics guided dementia discovery in Cambridge, Massachusetts

Jun 04, 2019: Patrick Coyle appointed Vice President and Chief Financial Officer of Eisai

May 29, 2019: Adriana Herrera appointed senior vice president, Americas commercial oncology at Eisai

May 02, 2019: Eisai deepens its commitment to Alzheimer's disease with key executive appointments

May 01, 2019: Eisai acquires rights to lemborexant from Purdue Pharma

Mar 13, 2019: TRIA to design new dementia discovery center for Eisai

Sep 06, 2018: Oncodesign furthers its cooperation with Eisai, started 12 years ago

Aug 31, 2018: XingImaging announces alzheimer's disease PET imaging in Mainland China

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eisai Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Eisai Inc, Key Facts

Eisai Inc, Key Employees

Eisai Inc, Key Employee Biographies

Eisai Inc, Major Products and Services

Eisai Inc, History

Eisai Inc, Other Locations

Eisai Inc, Subsidiaries

Eisai Inc, Key Competitors

Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Eisai Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Eisai Inc, Recent Deals Summary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Eisai Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Koronis Pharma Inc

Abraxis BioScience Inc

White River Health System

Research Foundation for Mental Hygiene Inc

Wellstat Therapeutics Corp

Salix Pharmaceuticals Ltd

Ceregene Inc

Adlyfe Inc

Predictive Biosciences Inc

AstraZeneca Plc